Recommendation 10:
CANCER SURVIVORS
All cancer survivors 3 to receive nutritional care from an appropriately trained professional (namely dietician)
If able to do so, and unless otherwise advised, aim to follow the recommendations for diet, healthy weight, and physical
Cancer survivors are people who are living with a diagnosis of cancer, including those who have recovered from the disease.
Awareness of cancer survival has increased greatly since the 1990s. So has the number of people living with a diagnosis of cancer. The total number of recorded cancer survivors in the world in 2002 was estimated to be just under 25 million.
This recommendation does not apply to those who are undergoing active cancer treatment.
Treatment for many cancers is increasingly successful, and so cancer survivors increasingly are living long enough to develop new primary cancers or other chronic diseases.
__________________________________________________________________
Cancer Vaccine?
A first-of-its-kind vaccine to prevent breast cancer is being developed by researchers at Cleveland Clinic's Lerner Research Institute, USA.
The researchers found that a single vaccination with the antigen α-lactalbumin prevents breast cancer tumors from forming in experimental mice, while also stop the growth of already existing tumors. Human trials could begin within the next year.
A first-of-its-kind vaccine to prevent breast cancer has shown overwhelmingly favorable results in animal models, according to a study by researchers at Cleveland Clinic's Lerner Research Institute.
The researchers found that a single vaccination with the antigen α-lactalbumin prevents breast cancer tumors from forming in mice, while also inhibiting the growth of already existing tumors. Human trials could begin within the next year. If successful, it would be the first vaccine to prevent breast cancer.
The research will be published online May 30 at http://www.nature.com/naturemedicine/ and in the June 10 issue of Nature Medicine.
"We believe that this vaccine will someday be used to prevent breast cancer in adult women in the same way that vaccines prevent polio and measles in children,"
said Vincent Tuohy, Ph.D.,
the study's principal investigator and an immunologist in Cleveland Clinic's Lerner Research Institute Department of Immunology. "If it works in humans the way it works in mice, this will be monumental. We could eliminate breast cancer."
Source: Cleveland Clinic's Lerner Research Institute
_______________________
CANCER SURVIVORS
All cancer survivors 3 to receive nutritional care from an appropriately trained professional (namely dietician)
If able to do so, and unless otherwise advised, aim to follow the recommendations for diet, healthy weight, and physical
Cancer survivors are people who are living with a diagnosis of cancer, including those who have recovered from the disease.
Awareness of cancer survival has increased greatly since the 1990s. So has the number of people living with a diagnosis of cancer. The total number of recorded cancer survivors in the world in 2002 was estimated to be just under 25 million.
This recommendation does not apply to those who are undergoing active cancer treatment.
Treatment for many cancers is increasingly successful, and so cancer survivors increasingly are living long enough to develop new primary cancers or other chronic diseases.
__________________________________________________________________
Cancer Vaccine?
A first-of-its-kind vaccine to prevent breast cancer is being developed by researchers at Cleveland Clinic's Lerner Research Institute, USA.
The researchers found that a single vaccination with the antigen α-lactalbumin prevents breast cancer tumors from forming in experimental mice, while also stop the growth of already existing tumors. Human trials could begin within the next year.
A first-of-its-kind vaccine to prevent breast cancer has shown overwhelmingly favorable results in animal models, according to a study by researchers at Cleveland Clinic's Lerner Research Institute.
The researchers found that a single vaccination with the antigen α-lactalbumin prevents breast cancer tumors from forming in mice, while also inhibiting the growth of already existing tumors. Human trials could begin within the next year. If successful, it would be the first vaccine to prevent breast cancer.
The research will be published online May 30 at http://www.nature.com/naturemedicine/ and in the June 10 issue of Nature Medicine.
"We believe that this vaccine will someday be used to prevent breast cancer in adult women in the same way that vaccines prevent polio and measles in children,"
said Vincent Tuohy, Ph.D.,
the study's principal investigator and an immunologist in Cleveland Clinic's Lerner Research Institute Department of Immunology. "If it works in humans the way it works in mice, this will be monumental. We could eliminate breast cancer."
Source: Cleveland Clinic's Lerner Research Institute
_______________________
Comments
Post a Comment